IONS Ionis Pharmaceuticals Inc.

$50.78 -2.16%

737,451 Shares Traded
1,015,563 Average Volume (last 30 days)

as of March 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $11.68 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-3.11%
If Intiated One Month Ago, Shorts Have Realized a Return of:-1.58%
If Initiated Five Days ago, Shorts Have Realized a Return of:1.76%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 8.35%
Short Interest10.43 million
Float124.88 million
Short Ratio11.57
Market Cap$6.37 billion
Market Maker ActivityDaily Short Volume


Akcea to commercialize Ionis Pharma's inotersen; shares up 28% (SeekingAlpha)
Ionis and Akcea Partner to Commercialize Inotersen for hATTR (PR Newswire)
Biogen's Spinraza shows positive effect in mid-stage study in pre-symptomatic infants with SMA (SeekingAlpha)
Ionis Is A Buy On RNA Platform Pipeline (SeekingAlpha)
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences (PR Newswire)
Ionis Pharmaceuticals (IONS) Top-line IONIS-HTT Rx (RG6042) Phase 1/2 Study Results - Slideshow (SeekingAlpha)
Biotech Analysis Central Pharma News: Biogen Pulls MS Drug, Roche's And Ionis' Huntington's Drug Advance, Idera's Hope (SeekingAlpha)
Your Daily Pharma Scoop: Conatus Rallies, Ionis Data, Reata's Omaveloxolone Fails In Mid-Stage Study (SeekingAlpha)
3 Things In Biotech, March 2: Shire Pushes, Acceleron Shines, And Antisense Goes On (SeekingAlpha)
Ionis Pharma's Huntington's disease candidate shows positive effect in Phase 1/2 study (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 73.2%

Earnings Stats

PE Ratio -1269.5
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $52.72
50 Day Moving Average $51.25
52 Week High $65.51
52 Week Low $37.26

Data provided for free by IEX. Questions? Read the FAQ